Literature DB >> 928258

Atenolol in hypertension a study of long-term therapy.

F J Zacharias, K J Cowen, P F Cuthbertson, T B Johnson, J Prestt, J Thompson, J Vickers, W T Simpson, R Tuson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928258

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  13 in total

Review 1.  Allopathy--the therapeutic legacy.

Authors:  G D Johnston
Journal:  Ir J Med Sci       Date:  1989-01       Impact factor: 1.568

Review 2.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 5.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

6.  Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.

Authors:  M K Tutton; R J Smith
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

7.  Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.

Authors:  M Velasco; J Guevara; J Morillo; A Ramírez; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

8.  Transplacental passage of atenolol in man.

Authors:  A Melander; B Niklasson; I Ingemarsson; H Liedholm; B Scherstén; N O Sjöberg
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

9.  Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.

Authors:  T Kaila; R Marttila
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

10.  Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.

Authors:  A Markel; J G Brook; Y Levy; M Aviram; M B Youdim
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.